17 results
Prophylaxis Against Opportunistic Infections in Persons with Human Immunodeficiency Virus Infection
#Pharm #Management #CD4Count #AIDS #HIV #Prophylaxis
Opportunistic Infections ... Immunodeficiency Virus ... Infection #Pharm #Management ... #CD4Count #AIDS ... #HIV #Prophylaxis
HIV Associated Infections Based on CD4 Count 

#Diagnosis #InfectiousDisease #CD4Count #HIV #AIDS #Opportunistic #Infections #OI #Table
HIV Associated Infections ... InfectiousDisease #CD4Count ... #HIV #AIDS #Opportunistic ... Infections #OI #Table ... #Prophylaxis #CD4
Prophylaxis to Prevent First Episode of Selected Opportunistic Infections
#Pharm #Management #CD4Count #AIDS #HIV #Prophylaxis #Prophylactic #Antibiotics
Prophylaxis to Prevent ... Episode of Selected Opportunistic ... Infections #Pharm #Management ... #CD4Count #AIDS ... #HIV #Prophylaxis
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Opportunistic ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Opportunistic ... HIVAIDS #IDSA #management ... #pharmacology
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... (HCV) infection ... DAAs #Antivirals #table ... HepC #HepatitisC #Management ... #Pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... to 5 mg/kg/day IV ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Antimicrobial prophylaxis ... antimicrobial prophylaxis ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... chew, or crush tablet ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General Management ... Therapy (Secondary Prophylaxis ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology